CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Alkylating Activity [MoA] Brain Neoplasms [Disease/Finding] Carcinoma [Disease/Finding] Colonic Neoplasms [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Ependymoma [Disease/Finding] Glioblastoma [Disease/Finding] Hodgkin Disease [Disease/Finding] Lung Neoplasms [Disease/Finding] Lymphoma, Non-Hodgkin [Disease/Finding] Medulloblastoma [Disease/Finding] Melanoma [Disease/Finding] Multiple Myeloma [Disease/Finding] Neutropenia [Disease/Finding] Thrombocytopenia [Disease/Finding] Carmustine [Chemical/Ingredient] Decreased DNA Integrity [PE] Decreased DNA Replication [PE] Pregnancy [Disease/Finding] C [Preparations] CARMUSTINE http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017422s042lbl.pdf C12294 Carmustine <VANDF_Record>50.6^455^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>455</VA_IEN> CARMUSTINE C0007257 N0000146473 U68WG3173Y Active 4018136 <VANDF_Record>50.416^733^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>733</VA_IEN> Ingredient 2105 brain cancer nausea AE vomiting AE hematotoxicity AE renal failure AE